CMS Issues Pair of Rules on Line Item Extension Drugs

CMS issues pair of final rules addressing line item extension drugs.

The Centers for Medicare and Medicaid Services (CMS) has issued an interim final rule revising the calculation of rebates for line item extension drugs and a final rule declining to finalize proposed regulatory change to the definition of “line item extension drugs.”

Comments on the rules are due in late May.